MT-102(Myeloid Therapeutics)

N/A

Report date: 2022/12/27 14:42:22

Base Information

Drug NameMT-102(Myeloid Therapeutics)
Drug Alias NameMT-102
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionImmunologic cytotoxicityCell replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMyeloid Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A